Expert Insights & Commentary
BLOG
The South Florida Venture Tech Chronicle Blog goes beyond the headlines.
Here, founders, investors, and industry experts share their perspectives on emerging technologies, investment strategies, and the challenges shaping our innovation ecosystem.
Expect thought leadership, data-driven opinions, and long-form features that deepen understanding of where tech is headed next.
The GLP-1 Gold Rush: What eMed, Tom Brady, and the Telehealth Boom Mean for South Florida’s Business Community
GLP-1 medications like Ozempic and Wegovy are no longer just celebrity headlines — they are rapidly becoming a strategic lever in employer-sponsored healthcare. With eMed appointing Tom Brady as chief wellness officer and expanding structured GLP-1 programs, the conversation has shifted from weight loss to workforce performance.
For South Florida’s business community, this telehealth-driven shift intersects cost control, talent retention and long-term health outcomes. As employers weigh fast-access digital prescriptions against structured, data-driven population health models, the GLP-1 surge signals more than a wellness trend — it marks a strategic inflection point for corporate healthcare strategy.